FGP
OGN icon

Freestone Grove Partners’s Organon & Co OGN Stock Holding History

Freestone Grove Partners’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30,774
Closed -$184K – 1243
2026
Q1 		$184K Sell
30,774
-22,963
-43% -$173K ﹤0.01% 747
2025
Q4 		$385K Buy
+53,737
New +$425K ﹤0.01% 620

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Freestone Grove Partners's OGN Position: Q2 2026 in Review

Freestone Grove Partners sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 30,774 shares — an estimated $184K sold.

Freestone Grove Partners first reported a position in OGN in Q4 2025 and held it in 2 quarters. The position peaked at $385K in Q4 2025. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Freestone Grove Partners reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Freestone Grove Partners sold 30,774 Organon & Co shares in Q2 2026, an estimated $184K.
  • Freestone Grove Partners first reported a position in Organon & Co in Q4 2025 and held it in 2 quarters.
  • Freestone Grove Partners's Organon & Co position peaked at $385K in Q4 2025.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.